ImpediMed

(ASX) IPD

Current PriceA$0.01

Market CapA$14.04M

Since IPO (2007)-99%

5 Year-95%

1 Year-81%

1 Month-25%

ImpediMed Financials at a Glance

Market Cap

A$14.04M

Revenue (TTM)

A$25.78M

Net Income (TTM)

-A$45.59M

EPS (TTM)

-A$0.01

P/E Ratio

-0.50

Dividend

A$0.00

Beta (Volatility)

-0.08 (Low)

Dividend

A$0.00

Beta (Volatility)

-0.08 (Low)

Price

A$0.01

Volume

10,276,893

Open

A$0.01

Price

A$0.01

Volume

10,276,893

Open

A$0.01

Previous Close

A$0.01

Daily Range

A$0.01 - A$0.01

52-Week Range

A$0.01 - A$0.06

Estimated Earnings Date

Aug 27, 2026

Dividend

A$0.00

Beta (Volatility)

-0.08 (Low)

Price

A$0.01

Volume

10,276,893

Open

A$0.01

Previous Close

A$0.01

Daily Range

A$0.01 - A$0.01

52-Week Range

A$0.01 - A$0.06

Estimated Earnings Date

Aug 27, 2026

IPD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ImpediMed

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Parmjot Bains, PhD

Website

www.impedimed.com

Headquarters

Pinkenba, QLD 4008, AU

IPD Financials

Key Financial Metrics (TTM)

Gross Margin

-6%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-118%

Return on Capital

-71%

Return on Assets

-64%

Earnings Yield

-2.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$14.04M

Shares Outstanding

2.34B

Volume

10.28M

Avg. Volume

5.89M

Financials (TTM)

Gross Profit

A$10.98M

Operating Income

-A$24.23M

EBITDA

-A$17.55M

Operating Cash Flow

-A$14.65M

Capital Expenditure

-A$989.00K

Free Cash Flow

-A$15.63M

Cash & ST Invst.

A$22.18M

Total Debt

A$14.49M

ImpediMed Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$7.52M

+57.1%

Gross Profit

-A$6.52M

+16.8%

Gross Margin

-86.70%

N/A

Market Cap

A$14.04M

N/A

Market Cap/Employee

A$169.11K

N/A

Employees

N/A

Net Income

-A$12.28M

-26.4%

EBITDA

-A$7.51M

+16.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$18.85M

-48.9%

Total Debt

A$21.93M

+1623.0%

Accounts Receivable

A$3.76M

+41.1%

Inventory

A$2.27M

+152.2%

Long Term Debt

A$21.63M

+2146.2%

Short Term Debt

A$303.00K

-2.3%

Return on Assets

-63.53%

N/A

Return on Invested Capital

-70.68%

N/A

Free Cash Flow

A$0.00

+100.0%

Operating Cash Flow

-A$9.50M

-40.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GSS.AXGenetic Signatures Limited

GSS.AXGenetic Signatures LimitedA$0.07+4.23%

MX1.AXMicro-X Limited

MX1.AXMicro-X LimitedA$0.04+5.71%

PCK.AXPainChek Limited

PCK.AXPainChek LimitedA$0.13-3.70%

EYE.AXNova Eye Medical Limited

EYE.AXNova Eye Medical LimitedA$0.12+6.67%

MVP.AXMedical Developments International Limited

MVP.AXMedical Developments International LimitedA$0.39+1.32%

CMP.AXCompumedics Limited

CMP.AXCompumedics LimitedA$0.24-2.04%

ATX.AXAmplia Therapeutics Limited

ATX.AXAmplia Therapeutics LimitedA$0.11+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About IPD

What is the current price of ImpediMed?

ImpediMed is trading at A$0.01 per share.

What is the 52-week range for ImpediMed?

Over the past 52 weeks, ImpediMed has traded between A$0.01 and A$0.06.

How much debt does ImpediMed have?

As of the most recent reporting period, ImpediMed reported total debt of A$14.49M.

How much cash does ImpediMed have on hand?

ImpediMed reported A$22.18M in cash and cash equivalents in its most recent financial results.

What is ImpediMed’s dividend yield?

ImpediMed does not currently have a dividend yield.

ImpediMed

ImpediMed Financials at a Glance

IPD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ImpediMed

IPD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ImpediMed Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IPD

What is the current price of ImpediMed?

What is the 52-week range for ImpediMed?

How much debt does ImpediMed have?

How much cash does ImpediMed have on hand?

What is ImpediMed’s dividend yield?

Premium Investing Services